Human papillomavirus prevalence among men in sub-Saharan Africa: A systematic review and meta-analysis

Sexually Transmitted Infections

Volumn 90, Issue 6, 2014, Pages 455-462

  Olesen, Tina Bech ^a   Munk, Christian ^a   Christensen, Jane ^a   Andersen, Klaus Kaae ^a   Kjaer, Susanne K ^a,b  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

AFRICA SOUTH OF THE SAHARA; HETEROSEXUAL MALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; MALE; PAPILLOMAVIRUS INFECTION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; ADOLESCENT; ADULT; AFRICA; AGE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; META ANALYSIS; MIDDLE AGED; MIXED INFECTION; SYSTEMATIC REVIEW (TOPIC); VIROLOGY; WART VIRUS; YOUNG ADULT;

AFRICA; HPV; MEN; META-ANALYSIS; SYSTEMATIC REVIEWS;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; AGE FACTORS; COINFECTION; HIV INFECTIONS; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 6; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; YOUNG ADULT;

EID: 84907287798     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2013-051456     Document Type: Review

References (45)

1. IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, France: Volume 90: Human Papillomaviruses, 2007.
2. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006;24 (Suppl 3):S3-11-/25.
3. Munoz N, Bosch FX, de SS, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
4. Miralles-Guri C, Bruni L, Cubilla AL, et al. Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol 2009;62:870-8.
5. Munoz N, Bosch FX, Castellsague X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004;111:278-85.
6. Kreimer AR, Clifford GM, Boyle P, et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005;14:467-75.
7. Schiller JT, Castellsague X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 2012;30(Suppl 5):F123-38.
8. Smith JS, Gilbert PA, Melendy A, et al. Age-specific prevalence of human papillomavirus infection in males: a global review. J Adolesc Health 2011;48:540-52.
9. Dunne EF, Nielson CM, Stone KM, et al. Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis 2006;194:1044-57.
10. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
11. Iftner T, Villa LL. Chapter 12: Human papillomavirus technologies. J Natl Cancer Inst Monogr 2003;80-8.
12. Smith JS, Backes DM, Hudgens MG, et al. Prevalence and risk factors of human papillomavirus infection by penile site in uncircumcised Kenyan men. Int J Cancer 2010;126:572-7.
13. Mbulawa ZZ, Marais DJ, Johnson LF, et al. Influence of human immunodeficiency virus and CD4 count on the prevalence of human papillomavirus in heterosexual couples. J Gen Virol 2010;91:3023-31.
14. United Nations Statistics Division. Composition of macro geographical (continental) regions, geographical sub-rehions, and selected economic and other groupings. New York. Accessed 13-3-2014.
15. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. The Cochrane Collaboration, 2008.
16. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
17. R: A Language and Environment for Statistical Computing, R Core Team, R Foundation for Statistical Computing. 2013. Vienna, Austria.
18. Vogt SL, Gravitt PE, Martinson NA, et al. Concordant Oral-Genital HPV Infection in South Africa Couples: Evidence for Transmission. Front Oncol 2013;3:303.
19. Ng'ayo MO, Bukusi E, Rowhani-Rahbar A, et al. Epidemiology of human papillomavirus infection among fishermen along Lake Victoria Shore in the Kisumu District, Kenya. Sex Transm Infect 2008; 84: 62-6.
20. Müller EE, Chirwa TF, Lewis DA. Human papillomavirus (HPV) infection in heterosexual South African men attending sexual health services: associations between HPV and HIV serostatus. Sex Transm Infect 2010;86:175-80.
21. Firnhaber C, Sello M, Maskew M, et al. Human papillomavirus types in HIV seropositive men with penile warts in Johannesburg, South Africa. Int J STD AIDS 2011;22:107-9.
22. Veldhuijzen NJ, Dhont N, Vyankandondera J, et al. Prevalence and concordance of HPV, HIV, and HSV-2 in heterosexual couples in Kigali, Rwanda. Sex Transm Dis 2012;39:128-35.
23. Olesen TB, Iftner T, Mwaiselage J, et al. Prevalence and Type-Distribution of Human Papillomavirus among 1, 813 Men in Tanzania and the Relationship to HIV Status. Sex Transm Dis 2013;40:592-8.
24. Tobian AA, Grabowski MK, Kigozi G, et al. High-risk human papillomavirus prevalence is associated with HIV infection among heterosexual men in Rakai, Uganda. Sex Transm Infect 2013;89:122-7.
25. Vardas E, Giuliano AR, Goldstone S, et al. External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents. J Infect Dis 2011;203:58-65.
26. Auvert B, Lissouba P, Cutler E, et al. Association of oncogenic and nononcogenic human papillomavirus with HIV incidence. J Acquir Immune Defic Syndr 2010;53:111-16.
27. Westercamp N, Mattson CL, Bailey RC. Measuring Prevalence and Correlates of Concurrent Sexual Partnerships Among Young Sexually Active Men in Kisumu, Kenya. AIDS Behav 2013;17:3124-32.
28. Morris M, Epstein H, Wawer M. Timing is everything: international variations in historical sexual partnership concurrency and HIV prevalence. PLoS One 2010;5: e14092.
29. Bruni L, Diaz M, Castellsague X, et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010;202:1789-99.
30. Tobian AA, Kigozi G, Gravitt PE, et al. Human papillomavirus incidence and clearance among HIV-positive and HIV-negative men in sub-Saharan Africa. AIDS 2012;26:1555-65.
31. Gravitt PE. The known unknowns of HPV natural history. J Clin Invest 2011;121:4593-9.
32. Houlihan CF, Larke NL, Watson-Jones D, et al. Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. AIDS 2012;26:2211-22.
33. Larke N, Thomas SL, Dos SSI, et al. Male circumcision and human papillomavirus infection in men: a systematic review and meta-analysis. J Infect Dis 2011;204:1375-90.
34. Tobian AA, Serwadda D, Quinn TC, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med 2009;360:1298-309.
35. Serwadda D, Wawer MJ, Makumbi F, et al. Circumcision of HIV-infected men: effects on high-risk human papillomavirus infections in a randomized trial in Rakai, Uganda. J Infect Dis 2010;201:1463-9.
36. Auvert B, Sobngwi-Tambekou J, Cutler E, et al. Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa. J Infect Dis 2009;199:14-9.
37. Gray RH, Serwadda D, Kong X, et al. Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: a randomized trial in Rakai, Uganda. J Infect Dis 2010;201:1455-62.
38. Szabo R, Short RV. How does male circumcision protect against HIV infection? BMJ 2000;320:1592-4.
39. Liu CM, Hungate BA, Tobian AA, et al. Male circumcision significantly reduces prevalence and load of genital anaerobic bacteria. MBio 2013;4:e00076.
40. Jalal H, Stephen H, Bibby DF, et al. Molecular epidemiology of genital human papillomavirus and Chlamydia trachomatis among patients attending a genitourinary medicine clinic-will vaccines protect? Int J STD AIDS 2007;18:617-21.
41. Barzon L, Militello V, Pagni S, et al. Distribution of human papillomavirus types in the anogenital tract of females and males. J Med Virol 2010;82:1424-30.
42. Vriend HJ, Bogaards JA, van der Klis FR, et al. Patterns of human papillomavirus DNA and antibody positivity in young males and females, suggesting a site-specific natural course of infection. PLoS One 2013;8:e60696.
43. de Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses. Virology 2004;324:17-27.
44. Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet 2007;370:890-907.
45. Dartell M, Rasch V, Kahesa C, et al. Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT study. Sex Transm Dis 2012;39:201-8.